These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. US Supreme Court decision could compromise biotech patents. Robertson D Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981 [No Abstract] [Full Text] [Related]
28. US Supreme Court applies strict limits to patents. Robertson D Nat Biotechnol; 2002 Jul; 20(7):639. PubMed ID: 12089532 [No Abstract] [Full Text] [Related]
29. Biotechnology: a challenge for Hippocrates. Huynen S Auckl Univ Law Rev; 1991; 6(4):534-51. PubMed ID: 16127862 [No Abstract] [Full Text] [Related]
30. Super-enzyme patents get their day in court. Cyranoski D Nature; 2002 Oct; 419(6909):767. PubMed ID: 12397315 [No Abstract] [Full Text] [Related]
31. Biotech critic tries to sew up research on chimaeras. Check E Nature; 2003 Jan; 421(6918):4. PubMed ID: 12511921 [No Abstract] [Full Text] [Related]
32. Accord could lift block on European biotech patents. Abbott A Nature; 1997 Jun; 387(6636):835. PubMed ID: 9202106 [No Abstract] [Full Text] [Related]
33. Genomics companies welcome US PTO initiative on DNA patents. Marshall A Nat Biotechnol; 1997 Feb; 15(2):121-2. PubMed ID: 9035129 [No Abstract] [Full Text] [Related]
34. Patents. U.S. Supreme Court delves into what is and isn't patentable. Marshall E Science; 2009 Jun; 324(5933):1374. PubMed ID: 19520926 [No Abstract] [Full Text] [Related]
35. Ordering life: law and the normalization of biotechnology. Jasanoff S Not Polit; 2001; 17(62):34-50. PubMed ID: 15468485 [No Abstract] [Full Text] [Related]
36. The patentability of human-animal chimeras. Magnani TA Berkeley Technol Law J; 1999; 14():443-60. PubMed ID: 15732205 [No Abstract] [Full Text] [Related]
37. Patentable subject matter, TRIPS and the European Biotechnology Directive: Australia and patenting human genes. Palombi L Univ N S W Law J; 2003; 26(3):782-92. PubMed ID: 16617532 [No Abstract] [Full Text] [Related]
38. A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception. Hoffman DC Cornell Law Rev; 2004 May; 89(4):993-1043. PubMed ID: 15174465 [No Abstract] [Full Text] [Related]